Related Experiment Video
Updated: Jul 3, 2025

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Characterization of a new Pseudomonas aeruginosa Queuovirinae bacteriophage
Lauren E Whiteley1,2, Marvin Whiteley1,2
1School of Biological Sciences, Center for Microbial Dynamics and Infection, Georgia Institute of Technology, Atlanta, Georgia, USA.
Abstract:
The ESKAPEE pathogen Pseudomonas aeruginosa is a common cause of chronic wound and cystic fibrosis lung infections, as well as acute burn and nosocomial infections. Many of these infections are recalcitrant to conventional antibiotic therapies due to both traditional antibiotic resistance mechanisms and antimicrobial tolerance. Recent successes with bacteriophage (phage) therapy to treat chronic human P. aeruginosa infections have led to a renewed interest in isolating and characterizing new P. aeruginosa phages. Here, we isolated and characterized a new lytic phage (termed PIP, pili-infecting phage) capable of infecting P. aeruginosa PA14. PIP is a tailed phage with an icosahedral head and flexible tail containing a genome that is 57,462 bp in length. Phylogenetic analysis reveals that PIP belongs to the subfamily Queuovirinae and genus Nipunavirus but is highly divergent in gene content from known Nipunaviruses. By isolating and characterizing a P. aeruginosa strain that spontaneously evolved resistance to PIP, we show that the receptor for PIP is Type IV pili. In summary, we isolated a new P. aeruginosa phage species with a unique genome, thus increasing the diversity of phages known to infect this important human pathogen.IMPORTANCEThe opportunistic pathogen Pseudomonas aeruginosa causes both acute and chronic human infections. These infections are notoriously difficult to treat due to both antibiotic resistance and antibiotic tolerance. The increasing frequency of antibiotic failure in P. aeruginosa infections has led scientists to explore other treatment options, including bacteriophage (phage) therapy. To this end, there has been a significant effort to identify new Pseudomonas phages. Here, we isolated and characterized a bacteriophage (termed PIP, pili-infecting phage) that infects P. aeruginosa PA14. Examination of the PIP genome revealed that this phage represents a new species in the subclass Queuovirinae. The isolation and characterization of spontaneous PA14 mutants that are resistant to PIP infection revealed Type IV pili as the PIP receptor. Ultimately, this study characterizes a new species of Pseudomonas phage, thus enhancing the known diversity of phages that infect this important pathogen.
Insights
Researchers discovered a new bacteriophage, PIP, that infects the problematic pathogen Pseudomonas aeruginosa. This pili-infecting phage, with a unique genome, offers a novel therapeutic avenue for difficult-to-treat infections.
Area of Science:
- Microbiology and Virology
- Bacteriophage Therapy
- Antimicrobial Resistance Research
Background:
- Pseudomonas aeruginosa is a significant ESKAPEE pathogen causing chronic and acute infections.
- Infections are often resistant to antibiotics due to resistance and tolerance mechanisms.
- Bacteriophage therapy is a promising alternative for treating P. aeruginosa infections.
Purpose of the Study:
- To isolate and characterize novel bacteriophages targeting P. aeruginosa.
- To investigate the receptor specificity of newly identified phages.
- To expand the diversity of known phages for potential therapeutic applications.
Main Methods:
- Isolation and characterization of a lytic bacteriophage, termed PIP, from P. aeruginosa PA14.
- Genomic sequencing and phylogenetic analysis of the PIP phage.
- Isolation and characterization of P. aeruginosa mutants resistant to PIP to identify the phage receptor.
Main Results:
- A novel lytic phage, PIP, with a 57,462 bp genome was isolated and characterized.
- Phylogenetic analysis placed PIP in the Queuovirinae subfamily and Nipunavirus genus, but with divergent gene content.
- Type IV pili were identified as the specific receptor for PIP infection in P. aeruginosa.
Conclusions:
- PIP represents a new species of Pseudomonas phage, increasing the diversity of known phages.
- The identification of Type IV pili as the receptor provides insights into phage-host interactions.
- This discovery contributes to the development of bacteriophage therapy against P. aeruginosa.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages

